Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-27

Clinical Trial Update: Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

View source ↗

Summary

An observational registry study (SIRtain Registry) evaluating the use of SIR-Spheres Y-90 resin microspheres for unresectable liver tumors. The study includes h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIR-Spheres Y-90 resin microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: Sirtex Medical | Conditions: Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) | Status: RECRUITING